Caffeines Impact on Semaglutide-Assisted Weight Loss Semaglutide, a medication mimicking the hormone GLP-1, aids weight loss by regulating appetite and food intake, making you feel full longer
1 Emerging and investigational directions being discussed in the literature include: Personalized risk stratification , using dose, sex, rate of weight loss, and baseline hair status to predict which patients need proactive hair-protective counseling before starting a GLP-1
Ready to take your transformation to the next level
Key Leaders: Tien Lee, MD, Founder & CEO
Novo Nordisk on Friday released headline data from the Phase III REDEFINE 1 trial of its next-generation weight-loss therapy CagriSema, touting superior weight loss in people with obesity and overweight than just cagrilintide, semaglutide (marketed as Wegovy for weight loss and Ozempic for diabetes) or placebo